U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
174901174901Whole Body Washing With Chlorhexidine for the Eradication of MRSACompletedNo Results AvailableMRSA-ColonizationDrug: Chlorhexidine solution 4%https://ClinicalTrials.gov/show/NCT00266448
174902174902The Usefulness of the HyperQ Stress System in Routine Annual Screening TestingCompletedNo Results AvailableCardiovascular Diseaseshttps://ClinicalTrials.gov/show/NCT00266435
174903174903Neurological Outcome of VLBW Infants With Early HypotensionCompletedNo Results Available1. VLBW Infants|2. Hypotensionhttps://ClinicalTrials.gov/show/NCT00266422
174904174904Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravamâ„¢ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic DisorderCompletedHas ResultsGeneralized Anxiety Disorder|Panic DisorderDrug: Niravam|Drug: SSRI/SNRIhttps://ClinicalTrials.gov/show/NCT00266409
174905174905Weight-Bearing Recommendation After Replacement of the Hip or Knee JointActive, not recruitingNo Results AvailableOsteoarthritisBehavioral: Weight-bearing recommendationhttps://ClinicalTrials.gov/show/NCT00266396
174906174906The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes PopulationCompletedNo Results AvailableTuberculosishttps://ClinicalTrials.gov/show/NCT00266383
174907174907A Pathology Reference Laboratory for the Study of Infectious Diseases and Malignant LymphomaRecruitingNo Results AvailableLymphomahttps://ClinicalTrials.gov/show/NCT00266370
174908174908Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)TerminatedNo Results AvailablePrimary InsomniaDrug: MK0928, gaboxadol / Duration of Treatment: 6 days for treatment periods (2 days/dose)|Drug: Placebo / Duration of Treatment: 2 days for screening periodhttps://ClinicalTrials.gov/show/NCT00266357
174909174909MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED)CompletedNo Results AvailablePrimary InsomniaDrug: MK0928, gaboxadol / Duration of Treatment 3 Weeks|Drug: Placebo / Duration of Treatment 3 Weekshttps://ClinicalTrials.gov/show/NCT00266344
174910174910RayGel-An Alternative for Skin Care During External Beam RadiationCompletedNo Results AvailableBreast CancerDrug: Reduced glutathionehttps://ClinicalTrials.gov/show/NCT00266331
174911174911Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior TherapyCompletedNo Results AvailableHepatitis CDrug: Interferon Alfacon-1 and Ribavirinhttps://ClinicalTrials.gov/show/NCT00266318
174912174912Fish Oil Supplementation in LactationCompletedNo Results AvailableDevelopment and HealthBehavioral: Fish oil (Dry n-3, BASF)https://ClinicalTrials.gov/show/NCT00266305
174913174913The Effect of n-3 LCPUFA on Immune Function and Cardiovascular Risk FactorsActive, not recruitingNo Results AvailableCardiovascular Heart Disease|Metabolic SyndromeBehavioral: Fish oil (Bio-Marine, Pharma Nord)|Behavioral: n-6 PUFA intake (Margarine+sunflower oil vs. butter product+rapeseed oil)https://ClinicalTrials.gov/show/NCT00266292
174914174914Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck MalignanciesCompletedHas ResultsHead or Neck CancerDrug: Oxaliplatin, Capecitabinehttps://ClinicalTrials.gov/show/NCT00266279
174915174915Human Papilloma Virus DNA Self-TestCompletedNo Results AvailablePapilloma Virus, Humanhttps://ClinicalTrials.gov/show/NCT00266266
174916174916A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of MetforminCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: GK Activator (2)|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT00266253
174917174917A Study of GK Activator (2) in Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: GK Activator (2)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00266240
174918174918A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background MethotrexateCompletedHas ResultsRheumatoid ArthritisDrug: placebo|Drug: rituximab|Drug: methotrexate|Drug: folatehttps://ClinicalTrials.gov/show/NCT00266227
174919174919Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel SyndromeTerminatedNo Results AvailableCarpal Tunnel SyndromeDrug: lidocaine patch 5%https://ClinicalTrials.gov/show/NCT00266214
174920174920Right Ventricular Failure in Congenital Heart DefectsCompletedNo Results AvailableHeart Failure|Congenital Heart Defectshttps://ClinicalTrials.gov/show/NCT00266201
174921174921Follow up of Post-repair Tetralogy of FallotCompletedNo Results AvailableTetralogy of Fallothttps://ClinicalTrials.gov/show/NCT00266188
174922174922Pulmonary Arteriopathy-Diagnostics and TherapyCompletedNo Results AvailablePulmonary Stenosishttps://ClinicalTrials.gov/show/NCT00266175
174923174923Bosentan in Treatment of Pulmonary Arterial HypertensionCompletedNo Results AvailableEisenmenger SyndromeDrug: Bosentan administrationhttps://ClinicalTrials.gov/show/NCT00266162
174924174924Lamotrigine and Oral ContraceptivesTerminatedNo Results AvailableEpilepsyDrug: Oral contraception|Drug: Lamotriginehttps://ClinicalTrials.gov/show/NCT00266149
174925174925Biology and Treatment Strategy of AML in Its Subgroups: Multicenter Randomized Trial by the German Acute Myeloid Leukemia Cooperative Group (AMLCG)CompletedNo Results AvailableAcute Myeloid LeukemiaDrug: Cytarabine|Drug: Thioguanine|Drug: Daunorubicin|Drug: Cyclophosphamide|Drug: G-CSF|Procedure: Autologous stem cell transplantation|Procedure: Allogeneic stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00266136
174926174926Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant RecipientsCompletedNo Results AvailableGraft Rejection|Kidney Failure|Kidney TransplantDrug: Sirolimushttps://ClinicalTrials.gov/show/NCT00266123
174927174927Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast CancerActive, not recruitingNo Results AvailableBreast CancerBiological: sargramostim|Biological: therapeutic autologous dendritic cells|Biological: trastuzumab|Drug: vinorelbine ditartratehttps://ClinicalTrials.gov/show/NCT00266110
174928174928Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract CancerCompletedNo Results AvailableExtrahepatic Bile Duct Cancer|Gallbladder Cancer|Pancreatic CancerDrug: erlotinib hydrochloride|Drug: gemcitabine hydrochloride|Drug: oxaliplatin|Radiation: radiation therapy|Drug: gemcitabine hydrochloride|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00266097
174929174929Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine CervixCompletedNo Results AvailableUterine Cervical Dysplasia|Uterine Cervical Intraepithelial Neoplasia|Uterine Cervical Neoplasia|Uterine Cervical Cancerhttps://ClinicalTrials.gov/show/NCT00266084
174930174930Study of the Cutaneous Microcirculation in Elderly PeopleNot yet recruitingNo Results AvailableElderly PeopleBehavioral: Cutaneous responsehttps://ClinicalTrials.gov/show/NCT00266071

* Görseller ve İçerik tekif hakkına sahip olabilir